Search
01/04/2025
Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia
Liu, XL, de Boer, SCM, Cortez, K, Poos, JM, Illán-Gala, I, Heuer, H, Forsberg, LK, Casaletto, K, Memel, M, Appleby, BS, Barmada, S, Bozoki, A, Clark, D, Cobigo, Y, Darby, R, Dickerson, BC, Domoto-Reilly, K, Galasko, DR, Geschwind, DH, Ghoshal, N, Graff-Radford, NR, Grant, IM, Hsiung, GYR, Honig, LS, Huey, ED, Irwin, D, Kantarci, K, Léger, GC, Litvan, I, Mackenzie, IR, Masdeu, JC, Mendez, MF, Onyike, CU, Pascual, B, Pressman, P, Bayram, E, Ramos, EM, Roberson, ED, Rogalski, E, Bouzigues, A, Russell, LL, Foster, PH, Ferry-Bolder, E, Masellis, M, van Swieten, J, Jiskoot, L, Seelaar, H, Sanchez-Valle, R, Laforce, R, Graff, C, Galimberti, D, Vandenberghe, R, de Mendonça, A, Tiraboschi, P, Santana, I, Gerhard, A, Levin, J, Sorbi, S, Otto, M, Pasquier, F, Ducharme, S, Butler, CR, Le Ber, I, Finger, E, Rowe, JB, Synofzik, M, Moreno, F, Borroni, B, Boeve, BF, Boxer, AL, Rosen, HJ, Pijnenburg, YAL, Rohrer, JD, Tartaglia, MC. Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.14608. PMID:40277074. IF:11.100(Q1/1D).
01/04/2025
Sex differences in the clinical manifestation of autosomal dominant frontotemporal dementia
Memel, M, Staffaroni, AM, Ilan-Gala, I, Castro, JG, Kornak, J, Tartaglia, CM, Saloner, R, VandeBunte, AM, Paolillo, EW, Cadwallader, CJ, Chen, C, Gorno-Tempini, ML, Mandelli, M, Apostolova, L, Graff-Radford, N, Litvan, I, Bayram, E, Pressman, PS, Miyagawa, T, Mackenzie, I, Goldman, J, Darby, RR, Appleby, BS, Petrucelli, L, Gendron, T, Heuer, HW, Forseberg, LK, Rojas, JC, Boeve, BF, Brushaber, N, Domoto-Reilly, K, Ghoshal, N, Lapid, M, Pascual, B, Lee, S, Ramos, EM, Ramanan, V, Rademakers, R, Rascovsky, K, Pantelyat, A, Masdeu, JC, Snyder, A, Boxer, AL, Rosen, HJ, Casaletto, K. Sex differences in the clinical manifestation of autosomal dominant frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.14630. PMID:40277077. IF:11.100(Q1/1D).
01/04/2025
Long-term prognostic impact of the left anterior descending coronary artery as the STEMI-related culprit vessel: subanalysis of the EXAMINATION-EXTEND trial
Vidal-Calés, P, Bujak, K, Rinaldi, R, Salazar-Rodríguez, A, Ortega-Paz, L, Gómez-Lara, J, Jiménez-Díaz, V, Jiménez, M, Jiménez-Quevedo, P, Diletti, R, Bordes, P, Campo, G, Silvestro, A, Maristany, J, Flores, X, De Miguel-Castro, A, Iñiguez, A, Ielasi, A, Tespili, M, Lenzen, M, Gonzalo, N, Tebaldi, M, Biscaglia, S, Romaguera, R, Gómez-Hospital, JA, Serruys, PW, Sabaté, M, Brugaletta, S. Long-term prognostic impact of the left anterior descending coronary artery as the STEMI-related culprit vessel: subanalysis of the EXAMINATION-EXTEND trial. REC, interventional cardiology. 2025; 7(2)DOI:10.24875/RECICE.M24000488. PMID:. IF:(Q/D).
01/04/2025
Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.
Sivera Mascaró R, García Sobrino T, Horga Hernández A, Pelayo Negro AL, Alonso Jiménez A, Antelo Pose A, Calabria Gallego MD, Casasnovas C, Cemillán Fernández CA, Esteban Pérez J, Fenollar Cortés M, Frasquet Carrera M, Gallano Petit MP, Giménez Muñoz A, Gutiérrez Gutiérrez G, Gutiérrez Martínez A, Juntas Morales R, Ciano-Petersen NL, Martínez Ulloa PL, Mederer Hengstl S, Millet Sancho E, Navacerrada Barrero FJ, Navarrete Faubel FE, Pardo Fernández J, Pascual Pascual SI, Pérez Lucas J, Pino Mínguez J, Rabasa Pérez M, Sánchez González M, Sotoca J, Rodríguez Santiago B, Rojas García R, Turon-Sans J, Vicent Carsí V, Sevilla Mantecón T. Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.. Neurologia. 2025; 40(3)DOI:10.1016/j.nrleng.2024.02.008. PMID:38431252. IF:(Q/D).
01/04/2025
New scoring balloon to treat moderate-to-severe calcified coronary lesions. The first-in-man Naviscore study
Peñaranda, AS, Peregrina, EF, Kockar, MJ, del Blanco, BG, Romani, S, Moreiras, JM, Bermúdez, EP, Rodrigues, A, Ojeda, S, López, NG, Regueiro, A, Frutos, AS. New scoring balloon to treat moderate-to-severe calcified coronary lesions. The first-in-man Naviscore study. REC, interventional cardiology. 2025; 7(2)DOI:10.24875/RECICE.M24000484. PMID:. IF:(Q/D).
01/04/2025
Meteorin-like protein plasma levels are associated with worse outcomes in de novo heart failure
Anido-Varela, L, Aragón-Herrera, A, González-Maestro, A, Bellas, CT, Tarazón, E, Solé-González, E, Martínez-Sellés, M, Guerra-Ramos, JM, Carrasquer, A, Morán-Fernández, L, García-Vega, D, Seoane-Blanco, A, Moure-González, M, Seijas-Amigo, J, Rodríguez-Penas, D, García-Seara, J, Moraña-Fernández, S, Vázquez-Abuín, X, Roselló-Lletí, E, Portolés, M, Eiras, S, Agra, RM, Alvarez, E, González-Juanatey, JR, Feijóo-Bandín, S, Lago, F. Meteorin-like protein plasma levels are associated with worse outcomes in de novo heart failure. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55(4)DOI:10.1111/eci.14380. PMID:39834188. IF:3.600(Q1/2D).